Medicare Enrolled
Dr. Hadas Skupsky, M.D.
Procedural Dermatology Physician · Long Beach, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Skupsky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Skupsky?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Skupsky
Dr. Hadas Skupsky is a procedural dermatology physician in Long Beach, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Skupsky performed 12,198 Medicare services across 3,239 unique beneficiaries.
Between the years covered by Open Payments, Dr. Skupsky received a total of $4,490 from 34 pharmaceutical and/or device companies across 188 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in procedural dermatology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Skupsky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 14% volume in CA
$4,490 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,198
Medicare services
Top 14% in CA for procedural dermatology physician
3,239
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~813 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Photodynamic therapy gel for precancerous skin | 5,800 | $1 | $3 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
2,438 | $63 | $122 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,187 | $6 | $34 |
| Tissue staining for diagnosis, additional An extra laboratory procedure to apply special stains to tissue slides for detailed examination. |
594 | $80 | $144 |
| Tissue staining for diagnosis, initial A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics. |
555 | $92 | $196 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
429 | $101 | $199 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
372 | $43 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
220 | $70 | $137 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
171 | $92 | $191 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
116 | $73 | $182 |
| Special stain test for organisms A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results. |
115 | $104 | $177 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
46 | $46 | $98 |
| Manual microscopic genetic analysis of tumor A laboratory test that uses a microscope to manually examine tumor tissue for genetic changes. |
38 | $109 | $220 |
| Light application with debridement to destroy precancerous skin growth This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths. |
31 | $246 | $477 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
23 | $91 | $192 |
| Special tissue stain, multiplex A laboratory procedure using special stains to examine tissue samples. This multiplex technique allows for the analysis of multiple markers on a single slide. |
20 | $151 | $394 |
| Pathology tissue examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis. |
15 | $38 | $111 |
| Skin growth shaving, 0.5 cm or less This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs. |
14 | $71 | $136 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
14 | $146 | $449 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,490
Total received (2018-2024)
Avg $641/year across 7 years
Top 33% in CA for procedural dermatology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
188
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,341 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$149 (3.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,357
2023
$1,647
2022
$725
2021
$337
2020
$18
2019
$74
2018
$332
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$268
GENZYME CORPORATION
$187
Regeneron Healthcare Solutions, Inc.
$173
LEO Pharma Inc.
$143
Lilly USA, LLC
$119
E.R. Squibb & Sons, L.L.C.
$101
MERZ NORTH AMERICA, INC.
$86
Janssen Biotech, Inc.
$79
Amgen Inc.
$52
PFIZER INC.
$32
Novartis Pharmaceuticals Corporation
$26
SUN PHARMACEUTICAL INDUSTRIES INC.
$26
Biofrontera Inc.
$24
Galderma Laboratories, L.P.
$21
Solta Medical, a division of Bausch Health US, LLC
$19
Top 3 companies account for 46.3% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$549
LEO Pharma Inc.
$451
AbbVie Inc.
$444
Janssen Biotech, Inc.
$395
GENZYME CORPORATION
$366
Regeneron Healthcare Solutions, Inc.
$363
Novartis Pharmaceuticals Corporation
$321
Lilly USA, LLC
$204
E.R. Squibb & Sons, L.L.C.
$131
Amgen Inc.
$130
Dermavant Sciences, Inc.
$108
MERZ NORTH AMERICA, INC.
$104
Sun Pharmaceutical Industries Inc.
$98
PFIZER INC.
$98
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
AbbVie, Inc.
$75
Almirall LLC
$74
Incyte Corporation
$73
SUN PHARMACEUTICAL INDUSTRIES INC.
$49
Galderma Laboratories, L.P.
$42
UCB, Inc.
$41
Allergan, Inc.
$34
Blueprint Medicines Corporation
$29
Lifenet Health
$26
Fresenius Kabi USA, LLC
$25
Biofrontera Inc.
$24
Kyowa Kirin, Inc.
$24
MAYNE PHARMA INC.
$22
Mayne Pharma Inc.
$21
Solta Medical, a division of Bausch Health US, LLC
$19
Helsinn Therapeutics (U.S.), Inc.
$19
Genentech USA, Inc.
$18
Journey Medical Corporation
$12
Allergan Inc.
$11
Top 3 companies account for 32.1% of all-time payments
Associated products mentioned in payments ›
ADBRY · AMELUZ · AYVAKIT · BLU-U · CIBINQO · COSENTYX · Cimzia · Clear & Brilliant · DORYX · DUPIXENT · EUCRISA · Enbrel · HUMIRA · Humira · IDACIO · Klisyri · LIBTAYO · OPZELURA · Odomzo · Otezla · Poteligeo · QBREXZA · REMICADE · RINVOQ · Rituxan · SKYRIZI · SPEVIGO · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · TheraGenesis Wound Matrix · Tremfya · VALCHLOR · VTAMA · Winlevi · Xeomin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Procedural dermatology physicians within 10 mi
24
Per 100K population
0.2
County median income
$87,760
Nearest hospital
UCI HEALTH-LAKEWOOD
2.7 mi
2.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Skupsky is a mixed practice specialist, with above-average Medicare volume (top 14% in CA), with low-engagement industry engagement, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Skupsky experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Skupsky performed 5,800 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Skupsky receive payments from pharmaceutical companies?
Yes. Dr. Skupsky received a total of $4,490 from 34 companies across 188 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Skupsky's costs compare to other procedural dermatology physicians in Long Beach?
Dr. Skupsky's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Skupsky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Procedural Dermatology Physicians in Long Beach
Browse procedural dermatology physicians in Long Beach ranked by procedure volume and transparency data.
Highest volume
Top Procedural Dermatology Physicians in CA
Procedural dermatology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Procedural Dermatology Physicians in CA
Which CA procedural dermatology physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
LEO Pharma Inc. Payments to Doctors
See all physicians who received payments from LEO Pharma Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology